• Price (EUR)46.63
  • Today's Change-1.06 / -2.21%
  • Shares traded7.28k
  • 1 Year change-7.99%
  • Beta--
Data delayed at least 20 minutes, as of Mar 22 2023 17:58 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • 0MSD:LSE price moved over -2.09% to 45.36
  • 0MSD:LSE trading volume exceeds daily average by +517.43%

Key statistics

On Wednesday, CompuGroup Medical SE & Co KgaA (0MSD:LSE) closed at 46.63, -20.76% below its 52-week high of 58.85, set on Apr 05, 2022.
52-week range
30.62Nov 03 202258.85Apr 05 2022
Short selling activity
Provided by S&P Global Market Intelligence
Previous close47.69
Average volume34.51k
Shares outstanding53.73m
Free float26.71m
P/E (TTM)33.66
Market cap2.54bn EUR
EPS (TTM)1.41
Annual div (ADY)0.50
Annual div yield (ADY)1.05%
Div ex-dateMay 20 2022
Div pay-dateMay 24 2022
Data delayed at least 20 minutes, as of Mar 22 2023 17:58 BST.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.